Harmony Biosciences Holdings, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

HRMY$33.55-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS


· · March 31, · · December 31,
· · 2026 · · 2025
ASSETS · · · ·
CURRENT ASSETS: · · · ·
Cash and cash equivalents	$589,398	$752,502
Investments, short-term	51,520	22,838
Trade receivables, net	108,222	96,787
Inventory, net	5,281	5,357
Prepaid expenses	16,801	16,014
Other current assets	7,595	13,516
Total current assets	778,817	907,014
NONCURRENT ASSETS:
Investments, long-term	229,555	107,127
Intangible assets, net	83,457	89,418
Deferred tax asset	153,562	149,699
Other noncurrent assets	26,433	18,373
Total noncurrent assets	493,007	364,617
TOTAL ASSETS	$1,271,824	$1,271,631
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Trade payables	$28,600	$17,693
Accrued compensation	6,726	18,443
Accrued expenses	150,107	191,039
Current portion of long-term debt	20,000	20,000
Other current liabilities	11,907	4,957
Total current liabilities	217,340	252,132
NONCURRENT LIABILITIES:
Long-term debt, net	138,814	143,663
Other noncurrent liabilities	5,321	5,618
Total noncurrent liabilities	144,135	149,281
TOTAL LIABILITIES	361,475	401,413
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS’ EQUITY:
Common stock—$0.00001 par value; 500,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 57,867,389 and 57,726,170 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	1	1
Additional paid in capital	717,370	708,968
Accumulated other comprehensive (loss) income	(413)	346
Retained earnings	193,391	160,903
TOTAL STOCKHOLDERS’ EQUITY	910,349	870,218
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$1,271,824	$1,271,631

UNAUDITED CONDENSED CONSOLIDATED

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.